Antiulcerants are a broad class of drugs used to treat stomach and intestine ulcers. H2 receptor antagonists, gastric mucosal protecting drugs, antacids, and antibiotics are some of the most often used antiulcerants today. Proton pump inhibitors are also utilised as a co-treatment in individuals who are at risk of gastrointestinal bleeding, such as those who are taking aspirin. Their use prevents the stomach and lower abdomen from producing gastric acid. Antiulcerant drugs have become increasingly important in the treatment of stomach ulcers due to the rising incidence of heartburn and indigestion caused by the production of excess of stomach acid.
MARKET SCOPE
The "Global Antiulcerant Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antiulcerant drugs market with detailed market segmentation by type and disease. The report provides key statistics on the market status of the leading antiulcerant drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type the market is segmented as, Proton pump inhibitors, H2 receptor antagonists, Antibiotics, Gastric mucosal protective drugs, Antacids and Prostaglandin agonists.
- Based on disease the market is segmented as, Stomach Ulcers, Leg Ulcers, Peptic Ulcers, Esophageal Ulcer, Bleeding Ulcer, Refractory Ulcer, Stress Ulcer, Mouth Ulcers, Venous Stasis Ulcers, Neuropathic Ulcers, Arterial Ulcers and Pressure Ulcers.
MARKET DYNAMICS
Drivers:
- Growing prevalence of ganstrointestinal disorders such as, ulcers, reflux diseases etc.
- Association of risk factors such as, unhealthy eating, lack of exercise are also expected to spur the market growth.
- Increasing demand for agents such as, H2 blockers, PPIs for management of gastric issues, such as, acidity, refluxes.
- Presence of strong pipeline of agents to treat various kind of ulcers is expected to fuel the market growth during the forecast period.
Restraints:
- However, patent expirations and chances of side effects associated with prolonged treatment are expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antiulcerant drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antiulcerant drugs market in these regions.
IMPACT OF COVID-19 ON ANTIULCERANT DRUGS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In this tough time the demand for antiulcer agents declined a bit but the sales of such agents is going on through OTC and E-commerce as patients cannot go to clinics often for their checkups. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the antiulcerant drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antiulcerant drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antiulcerant drugs in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antiulcerant drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Dr. Reddy's Laboratories, Ltd
- Cipla
- Glenmark
- Aristo Pharma
- Takeda Pharmaceutical Company Limited
- Salix Pharmaceuticals
- Zydus Cadila
- Pfizer, Inc
- Fourrts
- Himalaya Wellness Company